Pediatric Nephrology

, Volume 27, Issue 10, pp 1929–1935 | Cite as

Ambulatory blood pressure monitoring and cardiac hypertrophy in children with metabolic syndrome

  • Berna Kamaci Bostanci
  • Mahmut Civilibal
  • Murat Elevli
  • Nilgun Selcuk Duru
Original Article



The metabolic syndrome (MS), a cluster of potent risk factors for cardiovascular disease, is composed of insulin resistance, obesity, hypertension and hyperlipidemia. The aim of our study was to investigated the relationships between MS and left ventricular mass index (LVMI) in childhood MS. This study included 50 children and adolescents with MS aged between 7–18 years.


Thirty age- and sex-matched healthy children served as a control group. The diagnosis of MS was made according to the criteria adapted from the World Health Organization. They underwent clinical examination with causal blood pressure (BP) measurements, 24-hour ambulatory blood pressure monitoring (ABPM) and echocardiogram. Patients underwent echocardiography to detect left ventricular hypertrophy (LVH). LVMI was calculated as left ventricular mass/height2.7.


The mean age of MS group was 12.0 ± 3.1 years. The mean value of LVMI was 46.5 ± 11.5 g/m2.7 in the MS group and it was significantly higher than those in the healthy children. The prevalence of severe LVH was 12 % using adult criteria (LVM > 51 g/m2.7) and 44 % using pediatric criteria (LVM > 95th percentile). The mean daytime systolic BP load (β = 0.315, p = 0.003) and HOMA-IR (β = 0.368, p = 0.006) were found as the independent predictors of LVMI.


In conclusion, LVH occurs commonly in pediatric MS and is associated with systolic hypertension and insulin resistance. LVMI should be measured routinely for the predicting of cardiovascular risks in these patients.


Metabolic syndrome Ambulatory blood pressure monitoring Left ventricular mass index Children 


  1. 1.
    Strock GA, Cottrell ER, Abang AE, Buschbacher RM, Hannon TS (2005) Childhood obesity: a simple equation with complex variables. J Long Term Eff Med Implants 15:15–32PubMedCrossRefGoogle Scholar
  2. 2.
    (1997) Prevention and management of the global epidemic of obesity.Report of the WHO Consultation on Obesity. GenevaGoogle Scholar
  3. 3.
    Berenson GS (2002) Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. Am J Cardiol 90:3–7CrossRefGoogle Scholar
  4. 4.
    DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194PubMedCrossRefGoogle Scholar
  5. 5.
    Sahn DJ, DeMaria A, Kisslo J, Weiman A (1978) The Committee on M-mode standardization of the American Society of Echocardiography. Circulation 58:1072–1073PubMedCrossRefGoogle Scholar
  6. 6.
    Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458PubMedCrossRefGoogle Scholar
  7. 7.
    de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMedCrossRefGoogle Scholar
  8. 8.
    de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMedCrossRefGoogle Scholar
  9. 9.
    Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22(6):709–714PubMedCrossRefGoogle Scholar
  10. 10.
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRefGoogle Scholar
  11. 11.
    Wuhl E, Witte K, Soergel M, Mehls O, Schaefer F (2002) For the German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007PubMedCrossRefGoogle Scholar
  12. 12.
    Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, Mahoney L, McCrindle B, Mietus-Snyder M, Steinberger J, Daniels S, American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee (2008) Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 52(3):433–451PubMedCrossRefGoogle Scholar
  13. 13.
    Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 15:539–553CrossRefGoogle Scholar
  14. 14.
    Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827PubMedCrossRefGoogle Scholar
  15. 15.
    Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, IDF Consensus Group (2007) The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 8:299–306PubMedCrossRefGoogle Scholar
  16. 16.
    Viner RM, Segal TY, Lichtarowicz-Kyrnska E, Hindmarsh P (2005) Prevalence of insulin resistance syndrome in obesity. Arch Dis Child 90:10–14PubMedCrossRefGoogle Scholar
  17. 17.
    Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRefGoogle Scholar
  18. 18.
    Litwin M, Sladowska J, Syczewska M, Niemirska A, Daszkowska J, Antoniewicz J, Wierzbicka A, Wawer ZT (2008) Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension. Pediatr Nephrol 23(5):787–796PubMedCrossRefGoogle Scholar
  19. 19.
    de las Fuentes L, Brown AL, Mathews SJ, Waggoner AD, Soto PF, Gropler RJ, Dávila-Román VG (2007) Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur Heart J 28(5):553–559PubMedCrossRefGoogle Scholar
  20. 20.
    Ahn MS, Kim JY, Youn YJ, Kim SY, Koh SB, Lee K, Yoo BS, Lee SH, Yoon J, Park JK, Choe KH (2010) Cardiovascular parameters correlated with metabolic syndrome in a rural community cohort of Korea: the ARIRANG study. J Korean Med Sci 25(7):1045–1052PubMedCrossRefGoogle Scholar
  21. 21.
    Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374PubMedCrossRefGoogle Scholar
  22. 22. FM, Hatun S, Kalaca S (2008) Metabolic syndrome in obese Turkish children and adolescents: comparison of two diagnostic models. Turk J Pediatr 50:359–365Google Scholar
  23. 23.
    Messerli FH (1982) Cardiovascular effects of obesity and hypertension. Lancet 1:1165–1168PubMedCrossRefGoogle Scholar
  24. 24.
    Flynn JT (2011) Ambulatory blood pressure monitoring in children: imperfect yet essential. Pediatr Nephrol 26(12):2089–2094PubMedCrossRefGoogle Scholar
  25. 25.
    Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M (1989) The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580–585PubMedCrossRefGoogle Scholar
  26. 26.
    Landsberg L (1992) Obesity and hypertension: experimental data. J Hypertens Suppl 10:S195–S201PubMedCrossRefGoogle Scholar
  27. 27.
    Hall JE (2003) The kidney, hypertension and obesity. Hypertension 41:625–633PubMedCrossRefGoogle Scholar
  28. 28.
    Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH, American Heart Association Council on Nutrition, Physical Activity, and Metabolism (2004) Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 110:2952–2967PubMedCrossRefGoogle Scholar
  29. 29.
    Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76:699–701PubMedCrossRefGoogle Scholar
  30. 30.
    Daniels SR, Witt SA, Glascock B, Khoury PR, Kimball TR (2002) Left atrial size in children with hypertension: the influence of obesity, blood pressure, and left ventricular mass. J Pediatr 141:186–190PubMedCrossRefGoogle Scholar
  31. 31.
    Gutin B, Treiber F, Owens S, Mensah GA (1998) Relations of body composition to left ventricular geometry and function in children. J Pediatr 132:1023–1027PubMedCrossRefGoogle Scholar
  32. 32.
    Davis CL, Kapuku G, Snieder H, Kumar M, Treiber FA (2002) Insulin resistance syndrome and left ventricular mass in healthy young people. Am J Med Sci 324:72–75PubMedCrossRefGoogle Scholar
  33. 33.
    von Haehling S, Doehner W, Anker SD (2006) Obesity and the heart a weighty issue. J Am Coll Cardiol 47:2274–2276CrossRefGoogle Scholar
  34. 34.
    Doehner W, Anker SD, Coats AJ (2000) Defects in insulin action in chronic heart failure. Diabetes Obes Metab 2:203–212PubMedCrossRefGoogle Scholar
  35. 35.
    Marín-García J, Goldenthal MJ (2002) Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis. Cardiovasc Res 54:516–527PubMedCrossRefGoogle Scholar
  36. 36.
    Anker SD, von Haehling S (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 90:464–470PubMedCrossRefGoogle Scholar
  37. 37.
    Strauss DS (1984) Growth-stimulatory actions of insulin in vitro and in vivo. Endocr Rev 5:356–369CrossRefGoogle Scholar
  38. 38.
    Holmang A, Yoshida N, Jennische E, Waldenstrom A, Bjorntorp P (1996) The effects of hyperinsulinaemia on myocardialmass, blood pressure regulation and central haemodynamics in rats. Eur J Clin Invest 26:973–978PubMedCrossRefGoogle Scholar
  39. 39.
    Cuspidi C, Sala C, Zanchetti A (2007) Management of hypertension in patients with left ventricular hypertrophy. Curr Hypertens Rep 9(6):498–505PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2012

Authors and Affiliations

  • Berna Kamaci Bostanci
    • 1
  • Mahmut Civilibal
    • 2
  • Murat Elevli
    • 1
  • Nilgun Selcuk Duru
    • 1
  1. 1.Department of PediatricsHaseki Educational and Research HospitalIstanbulTurkey
  2. 2.Department of Pediatric NephrologyHaseki Educational and Research HospitalAtakoyTurkey

Personalised recommendations